$164.14 1.7%
DVA Stock Price vs. AI Score
Data gathered: November 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - DaVita (DVA)

Analysis generated June 4, 2024. Powered by Chat GPT.

DaVita Inc. is a leading provider of kidney dialysis services. With a mission to provide top-notch quality care for patients with chronic kidney failure or end-stage renal disease, DaVita operates kidney dialysis centers and provides related lab services primarily in the United States. In recent years, they have expanded their operations and focused on integrating innovative healthcare solutions to enhance patient outcomes.

Read full AI stock Analysis

Stock Alerts - DaVita (DVA)

company logo DaVita | October 30
Price is down by -7% in the last 24h.
company logo DaVita | September 18
Insider Alert: Rodriguez Javier is selling shares
company logo DaVita | September 2
Job postings are down by -57.9% in the last couple of days.
company logo DaVita | September 1
Job postings are down by 58.3% in the last couple of days.

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.


DaVita
Price $164.14
Target Price Sign up
Volume 707,760
Market Cap $13.2B
Year Range $126.11 - $165.19
Dividend Yield 0%
PE Ratio 17.39
Analyst Rating 0% buy
Industry Medical Care Facilities

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '243.26B581M2.68B215M722M2.500
Q2 '243.19B544M2.64B223M682M2.500
Q1 '243.07B550M2.52B240M671M2.260
Q4 '233.15B623M2.52B151M585M1.620
Q3 '233.12B565M2.56B247M684M2.620

Insider Transactions View All

Rodriguez Javier filed to sell 837,835 shares at $165.1.
September 17 '24
Rodriguez Javier filed to sell 887,835 shares at $162.9.
September 17 '24
ACKERMAN JOEL filed to sell 106,741 shares at $155.
August 29 '24
Rodriguez Javier filed to sell 897,716 shares at $155.9.
August 28 '24
ACKERMAN JOEL filed to sell 111,481 shares at $155.1.
August 29 '24

Congress Trading View All

Politician Filing Date Type Size
Gerald Moran
Republican
Jan 17, 24 Sell $1K - $15K
Gerald Moran
Republican
Jan 17, 24 Sell $1K - $15K
Thomas Tuberville
Republican
Jan 12, 24 Sell $1K - $15K

What is the Market Cap of DaVita?

The Market Cap of DaVita is $13.2B.

What is DaVita's PE Ratio?

As of today, DaVita's PE (Price to Earnings) ratio is 17.39.

What is the current stock price of DaVita?

Currently, the price of one share of DaVita stock is $164.14.

How can I analyze the DVA stock price chart for investment decisions?

The DVA stock price chart above provides a comprehensive visual representation of DaVita's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DaVita shares. Our platform offers an up-to-date DVA stock price chart, along with technical data analysis and alternative data insights.

Does DVA offer dividends to its shareholders?

As of our latest update, DaVita (DVA) does not offer dividends to its shareholders. Investors interested in DaVita should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of DaVita?

Some of the similar stocks of DaVita are Encompass Health, Brookdale Senior Living, Amedisys, Tenet Healthcare, and Encompass Health.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.